Total Payments
$240,452
2024 Payments
$55,771
Companies
60
Transactions
1,490
Medicare Patients
5,276
Medicare Billing
$578,239
Payment Breakdown by Category
Other$203,250 (84.5%)
Food & Beverage$35,678 (14.8%)
Education$1,019 (0.4%)
Travel$504.48 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $203,250 | 64 | 84.5% |
| Food and Beverage | $35,678 | 1,388 | 14.8% |
| Education | $1,019 | 35 | 0.4% |
| Travel and Lodging | $504.48 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $205,731 | 360 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $12,065 | 243 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,330 | 166 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $2,345 | 74 | $0 (2024) |
| Grifols USA, LLC | $1,598 | 64 | $0 (2024) |
| United Therapeutics Corporation | $1,193 | 21 | $0 (2022) |
| Philips Electronics North America Corporation | $1,013 | 49 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $951.09 | 12 | $0 (2024) |
| Mylan Specialty L.P. | $938.35 | 54 | $0 (2024) |
| GENZYME CORPORATION | $931.44 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,771 | 220 | GlaxoSmithKline, LLC. ($51,363) |
| 2023 | $61,277 | 221 | GlaxoSmithKline, LLC. ($57,138) |
| 2022 | $58,767 | 232 | GlaxoSmithKline, LLC. ($51,837) |
| 2021 | $41,788 | 205 | GlaxoSmithKline, LLC. ($34,672) |
| 2020 | $11,969 | 156 | GlaxoSmithKline, LLC. ($9,313) |
| 2019 | $4,507 | 198 | Boehringer Ingelheim Pharmaceuticals, Inc. ($999.74) |
| 2018 | $3,855 | 167 | AstraZeneca Pharmaceuticals LP ($567.82) |
| 2017 | $2,518 | 91 | Respiratory Technologies, Inc. ($446.39) |
All Payment Transactions
1,490 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Neurology | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.08 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Pulmonology | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Respiratory | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $43.24 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: PULMONOLOGY | ||||||
| 11/26/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Hyperkalemia | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $88.37 | General |
| Category: Immunology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $78.99 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,368 | 1,896 | $371,133 | $136,067 |
| 2022 | 14 | 1,246 | 1,909 | $379,535 | $135,694 |
| 2021 | 16 | 1,306 | 3,076 | $408,777 | $150,810 |
| 2020 | 15 | 1,356 | 2,035 | $458,710 | $155,668 |
Total Patients
5,276
Total Services
8,916
Medicare Billing
$578,239
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 376 | $80,840 | $34,771 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 171 | 274 | $63,259 | $25,975 | 41.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 122 | 204 | $29,402 | $13,011 | 44.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 69 | $53,780 | $11,790 | 21.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 72 | $27,936 | $9,824 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 155 | $22,475 | $9,704 | 43.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 144 | 162 | $17,496 | $6,891 | 39.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 151 | 170 | $18,530 | $6,852 | 37.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $20,040 | $6,755 | 33.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 179 | 212 | $15,476 | $4,141 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 23 | $6,624 | $3,073 | 46.4% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 18 | 20 | $5,800 | $1,969 | 34.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 82 | $8,200 | $888.00 | 10.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 17 | $1,275 | $421.44 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 404 | $86,860 | $36,494 | 42.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 196 | 386 | $89,017 | $31,247 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 208 | $30,160 | $13,363 | 44.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 126 | 213 | $30,246 | $12,052 | 39.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 67 | 69 | $27,184 | $10,350 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $26,720 | $9,413 | 35.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 43 | $34,660 | $7,180 | 20.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 83 | 90 | $9,720 | $3,960 | 40.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 85 | 92 | $10,028 | $3,694 | 36.8% |
| 71250 | Ct scan of chest without contrast | Office | 2022 | 28 | 35 | $10,150 | $3,246 | 32.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 131 | 145 | $10,585 | $2,750 | 26.0% |
About Dr. Maximo Lama, MD
Dr. Maximo Lama, MD is a Critical Care Medicine healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1326276445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maximo Lama, MD has received a total of $240,452 in payments from pharmaceutical and medical device companies, with $55,771 received in 2024. These payments were reported across 1,490 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($203,250).
As a Medicare-enrolled provider, Lama has provided services to 5,276 Medicare beneficiaries, totaling 8,916 services with total Medicare billing of $578,239. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Kissimmee, FL
- Active Since 06/26/2009
- Last Updated 05/12/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1326276445
Products in Payments
- TRELEGY ELLIPTA (Drug) $64,571
- AREXVY (Drug) $50,296
- BREZTRI (Drug) $7,317
- ANORO ELLIPTA (Drug) $3,806
- DUPIXENT (Biological) $1,849
- NUCALA (Biological) $1,746
- UPTRAVI (Drug) $1,638
- Prolastin-C Liquid (Biological) $1,308
- FASENRA (Biological) $1,256
- OFEV (Drug) $1,181
- FASENRA (Drug) $868.47
- TEZSPIRE (Biological) $826.91
- STIOLTO RESPIMAT (Drug) $802.47
- GLASSIA (Biological) $723.26
- Adempas (Drug) $694.25
- ORENITRAM (Drug) $687.42
- OPSUMIT (Drug) $637.68
- (8874) inCourage (Device) $610.63
- Yupelri (Drug) $610.01
- FARXIGA (Drug) $589.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Kissimmee
Dr. Thomas O'brien, Md, MD
Critical Care Medicine — Payments: $316,576
Critical Care Medicine $316,576
Remberto Bitar, M.d, M.D
Critical Care Medicine — Payments: $154,285
Critical Care Medicine $154,285
Nelson Medina Villanueva
Critical Care Medicine — Payments: $14,472
Critical Care Medicine $14,472
Dr. Adam Griggs, D.o, D.O
Critical Care Medicine — Payments: $11,873
Critical Care Medicine $11,873
Mrs. Dawna Hazelwood, Aprn Agacnp-Bc, APRN AGACNP-BC
Critical Care Medicine — Payments: $1,448
Critical Care Medicine $1,448
Rami Hanna, Md, MD
Critical Care Medicine — Payments: $16.95
Critical Care Medicine $16.95